$Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.(600196)$Established in 1994, Shanghai Fosun Pharma is an integrated healthcare group in China offering pharmaceutical products, medical devices, and healthcare services via its hospital network, and the healthcare arm of Fosun Group. Its vision is to become a first-tier enterprise in the global mainstream pharmaceutical and healthcare market. Fosun’s pharmaceutical portfolio contributed ~74% of 2021 revenue, while other key contributing segments were medical devices and healthcare services. In terms of geography, ~65% of its FY21 revenue was derived from China. While Fosun provides medium-term exposure to China’s growing demand for healthcare driven by increasing disposable income and aging populatio